Aeovian Pharmaceuticals has filed a notice of an exempt offering of securities to raise $50,415,077.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Aeovian Pharmaceuticals is raising up to $50,415,077.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Allison Hulme played a…
